JPMorgan Chase & Co. (JPM.MX)
| Previous close | 3,570.20 |
| Open | 3,607.00 |
| Bid | 3,611.01 x 500000 |
| Ask | 3,639.99 x 500000 |
| Day's range | 3,600.00 - 3,630.00 |
| 52-week range | 2,360.00 - 3,686.50 |
| Volume | |
| Avg. volume | 3,399 |
| Market cap | 10.428T |
| Beta (5Y monthly) | 1.11 |
| PE ratio (TTM) | 11.89 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 76.44 (2.14%) |
| Ex-dividend date | 05 July 2024 |
| 1y target est | N/A |
- Business Wire
Chase Freedom® Taps Into Summer Fun With Q3 2024 Cash Back Categories: Select Live Entertainment, Movie Theaters and Gas Stations, EV Charging
WILMINGTON, Del., June 17, 2024--Calling all live entertainment lovers, movie buffs and road trip adventurers! Chase Freedom is rolling out the red carpet for an epic summer of "cashbacking" adventures. Today, Chase Freedom unveiled its exciting new rotating bonus categories, giving Freedom and Freedom Flex cardmembers the chance to earn big while enjoying all the fun summer has to offer.
- Business Wire
JPMorgan Chase Declares Preferred Stock Dividends
NEW YORK, June 14, 2024--JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") has declared dividends on the outstanding shares of the Firm’s Series CC, FF and HH preferred stock. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.
- PR Newswire
J.P. Morgan Life Sciences Private Capital Closes Inaugural Biotechnology Venture Capital Fund with over $500 million in Commitments
J.P. Morgan Private Capital, a venture capital and growth equity investment team within J.P. Morgan Asset Management, today announced the final close of the first Life Sciences Private Capital offering, 270 Life Sciences Private Capital Fund I (the "Fund"), led by Chief Investment Officer Stephen Squinto, Ph.D. and Managing Partner Gaurav Gupta, M.D., M.S.E. The fund closed above its $500 million target, attracting strong support from investors, including institutional allocators, strategic corp
